Ceccaldi, Raphael <br/><br/>
A unique subset of epithelial ovarian cancers with platinum sensitivity and PARP inhibitor resistance.  [electronic resource] 

 -  Cancer research  Feb 2015 
 - 628-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-14-2593  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Carboplatin--administration & dosage<br/>Carcinoma, Ovarian Epithelial<br/>Cisplatin--administration & dosage<br/>DNA Breaks, Double-Stranded--drug effects<br/>DNA Repair--genetics<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm--genetics<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Humans<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Poly(ADP-ribose) Polymerases--genetics